Top Markets
Coin of the day
Chengdu Easton Biopharmaceuticals Co., Ltd. Chengdu Easton Biopharmaceuticals Co., Ltd.

Chengdu Easton Biopharmaceuticals Co., Ltd.

688513
주식 순위 #9010
Chengdu Easton Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise... Chengdu Easton Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise dedicated to the full spectrum of drug development, encompassing research, development, production, and market distribution of medicinal products. The company offers finished medications tailored for various medical disciplines, including pain management (anesthetics/analgesics), cardiovascular health, oncology, and pediatrics. Beyond ready-to-use drugs, it also manufactures active pharmaceutical ingredients (APIs) for a broader range of therapeutic areas, such as cancer treatment, heart conditions, pain relief, anti-inflammatory uses, gastrointestinal issues, antiemetics, neurological and psychiatric disorders, and urinary system ailments. Established in 2009, the firm is headquartered in Chengdu, China.
주가
$6.32
마지막 동기화: 2026-08-28
시가총액
$1.11B
변동 (1일)
-1.63%
변동 (1년)
-31.28%
국가
CN
거래 Chengdu Easton Biopharmaceuticals Co., Ltd. (688513)

카테고리

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513)의 EPS
2026 기준 EPS TTM: 0
Chengdu Easton Biopharmaceuticals Co., Ltd.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Chengdu Easton Biopharmaceuticals Co., Ltd.의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$17.32 -
US
$27.74 -
NL
$-5.29 -
AU
$-7.98 -
US
- -
CH